Keywords: تمایز نوروندوکرین; PCa; prostate cancer; CRPC; castration-resistant prostate cancer; NED; neuroendocrine differentiation; NE; neuroendocrine; CgA; chromogranin A; NSE; neuron specific enolase; TMA; tissue microarray; DNPC; double-negative prostate cancer; AR; androgen recep
مقالات ISI تمایز نوروندوکرین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: تمایز نوروندوکرین; NE; neuroendocrine; NED; neuroendocrine differentiation; NSCLC; non-small cell lung cancer; SCLC; small cell lung cancer; LCNEC; large-cell neuroendocrine carcinoma; PCa; prostate cancer; NSE; neuron specific enolase; CgA; choromogranin A; Syn; synaptophy
Keywords: تمایز نوروندوکرین; Bladder cancer; Small cell carcinoma; Urothelial carcinoma; Neuroendocrine differentiation; Immunohistochemistry; Retinoblastoma gene;
Keywords: تمایز نوروندوکرین; SCLC, small cell lung cancer; TTF-1, thyroid transcription factor 1; ASCL1, achaete-scute homolog like 1; NF1B, nuclear factor 1B; neuroendocrine differentiation; FFPE, formalin-fixed paraffin-embedded section;
Keywords: تمایز نوروندوکرین; Hepatocellular carcinoma; Neuroendocrine differentiation; Serum alpha-fetoprotein elevation;
Keywords: تمایز نوروندوکرین; Prostate cancer; Adenocarcinoma; Carcinoid; Neuroendocrine differentiation; Hormonal treatment;
Keywords: تمایز نوروندوکرین; Estrogen receptor-beta; Neuroendocrine differentiation; Capella type A and B;
Keywords: تمایز نوروندوکرین; Urachal neuroendocrine carcinoma; Small cell carcinoma; Adenocarcinoma; Large cell neuroendocrine carcinoma; Urachal nonglandular carcinoma; Neuroendocrine differentiation;
Keywords: تمایز نوروندوکرین; Prostate cancer; Hormonal blockade; Prognosis; Ki-67 index; Neuroendocrine differentiation;
Keywords: تمایز نوروندوکرین; Prostate cancer; Androgen deprivation; Gene expression; Modulation; TMPRSS2:ERG translocation; Neuroendocrine differentiation
Keywords: تمایز نوروندوکرین; Prostate cancer; Neuroendocrine differentiation; Prognosis; Pathology; Immunostaining;
Keywords: تمایز نوروندوکرین; Kidney; Chromophobe renal cell carcinoma; Neuroendocrine differentiation; Immunohistochemistry; Chromosomal numerical aberrations; aCGH
Keywords: تمایز نوروندوکرین; Prostate adenocarcinoma; Paneth cell; Neuroendocrine differentiation; Gleason grade
Keywords: تمایز نوروندوکرین; Chromophobe renal cell carcinoma; Neuroendocrine differentiation; Immunohistochemicalstain; Ultrastructure; Comparative genomic hybridization analysis
Metastatic primary neuroendocrine carcinoma of the breast (NECB)
Keywords: تمایز نوروندوکرین; Neuroendocrine breast carcinoma; Neuroendocrine differentiation; Neuroendocrine markers; Diagnosis; Treatment;
Tumeurs neuroendocrines primitives du sein : mythe ou réalité ? Une revue de la littérature
Keywords: تمایز نوروندوکرین; Carcinome neuroendocrine; Différenciation neuroendocrine; Sein; Diagnostic; Pronostic; Traitement; Neuroendocrine carcinoma; Neuroendocrine differentiation; Breast; Diagnosis; Prognosis; Treatment;
HOTAIR is a REST-regulated lncRNA that promotes neuroendocrine differentiation in castration resistant prostate cancer
Keywords: تمایز نوروندوکرین; Long non-coding RNAs; Castration-resistant prostate cancer; Neuroendocrine differentiation; REST; HOTAIR;
Immunohistochemical study of the neural development transcription factors (TTF1, ASCL1 and BRN2) in neuroendocrine prostate tumors
Keywords: تمایز نوروندوکرین; Achaete-scute homolog like 1; Transcription factor class III/IV POU3F2; Neuroendocrine differentiation; Small-cell carcinoma; Prostate cancer; Neural development transcription factors; Achaete-scute homolog like 1; Factor de transcripción clase III/IV PO
CYP17A1-independent production of the neurosteroid-derived 5α-pregnan-3β,6α-diol-20-one in androgen-responsive prostate cancer cell lines under serum starvation and inhibition by Abiraterone
Keywords: تمایز نوروندوکرین; 5-pregnan-3,6-diol-20-one; 4-Abiraterone; Neuroendocrine differentiation; Castration-resistant prostate cancer; CYP17A1; Neurosteroid; Steroidogenesis;
Original ArticleInduction of neuroendocrine differentiation in castration resistant prostate cancer cells by adipocyte differentiation-related protein (ADRP) delivered by exosomes
Keywords: تمایز نوروندوکرین; Adipocyte differentiation-related protein; Castration resistant prostate cancer; Adiposome; Neuroendocrine differentiation; Exosomes;
Sinonasal Small Round Blue Cell Tumors
Keywords: تمایز نوروندوکرین; Sinonasal tumors; Small round blue cell tumors; Immunohistochemistry; Cytokeratin; Squamous differentiation; Neuroendocrine differentiation;
Vulvar mucinous adenocarcinoma with neuroendocrine differentiation: A case report and review of the literature
Keywords: تمایز نوروندوکرین; FDG; fludeoxyglucose; CT-PET; computerized tomography-positron emission tomography; Mucinous adenocarcinoma; Neuroendocrine differentiation; Vulva;
Functional upregulation of the H2S/Cav3.2 channel pathway accelerates secretory function in neuroendocrine-differentiated human prostate cancer cells
Keywords: تمایز نوروندوکرین; Hydrogen sulfide; T-type calcium channel; Prostate cancer; Neuroendocrine differentiation
Regulation of T-type calcium channel expression by sodium butyrate in prostate cancer cells
Keywords: تمایز نوروندوکرین; LNCaP; lymph node carcinoma of the prostate; NaBu; sodium butyrate; NED; neuroendocrine differentiation; SAHA; suberoylanilide hydroxamic acid; 5׳-azaC; 5-azacytidine; NNC 55-0396 (PubChem CID: 11957578); Paclitaxel (PubChem CID: 36314); Sodium butyrate
Diferenciación neuroendocrina en cáncer de próstata. Revisión de la literatura
Keywords: تمایز نوروندوکرین; Diferenciación neuroendocrina; Cáncer de próstata; Neuroendocrine differentiation; Prostate cancer;
The orexin type 1 receptor is overexpressed in advanced prostate cancer with a neuroendocrine differentiation, and mediates apoptosis
Keywords: تمایز نوروندوکرین; Neuropeptide; G protein-coupled receptor; Neuroendocrine differentiation; Cancer; Apoptosis; Proliferation; Prostate cancer therapy
Prostate cancer with Paneth cell–like neuroendocrine differentiation has recognizable histomorphology and harbors AURKA gene amplification
Keywords: تمایز نوروندوکرین; Paneth cell–like; Neuroendocrine differentiation; AURKA amplification; MYCN amplification; Prostate cancer
Erk/MAP Kinase Signaling Pathway and Neuroendocrine Differentiation of Non–Small-Cell Lung Cancer
Keywords: تمایز نوروندوکرین; Non–small-cell lung cancer; Neuroendocrine differentiation; Cell signaling; Erk/mitogen-activated protein kinases
Secretogranin II is overexpressed in advanced prostate cancer and promotes the neuroendocrine differentiation of prostate cancer cells
Keywords: تمایز نوروندوکرین; Secretogranin; Secretory granule; Neuroendocrine differentiation; Prostate cancer;
Immunohistochemical analysis of chromogranin A and p53 expressions in ulcerative colitis-associated neoplasia: neuroendocrine differentiation as an early event in the colitis-neoplasia sequence
Keywords: تمایز نوروندوکرین; Dysplasia; Carcinoma; Ulcerative colitis; p53; Chromogranin A; Neuroendocrine differentiation;
The neuropeptide 26RFa is expressed in human prostate cancer and stimulates the neuroendocrine differentiation and the migration of androgeno-independent prostate cancer cells
Keywords: تمایز نوروندوکرین; Neuropeptide; G protein-coupled receptor; Neuroendocrine differentiation; Advanced prostate cancer;
Neuroendocrine Differentiation in Castration-Resistant Prostate Cancer: A Systematic Diagnostic Attempt
Keywords: تمایز نوروندوکرین; Castration-resistant prostate cancer; Neuroendocrine differentiation; Octreotide scintigraphy; Plasma chromogranin A; Somatostatin analogues; Tissular chromogranin A
Clinicopathological findings of non-small-cell lung cancer with high serum progastrin-releasing peptide concentrations
Keywords: تمایز نوروندوکرین; Non-small-cell lung cancer; Neuroendocrine differentiation; Tumor marker; proGRP; Immunohistochemistry; Chemotherapy;
Prognostic Significance of Neuroendocrine Differentiation in Patients With Gleason Score 8-10 Prostate Cancer Treated With Primary Radiotherapy
Keywords: تمایز نوروندوکرین; Prostate cancer; Neuroendocrine differentiation; Chromogranin A;
Small cell carcinoma of the kidney: a clinicopathologic study of 14 cases
Keywords: تمایز نوروندوکرین; Kidney; Small cell carcinoma; Urothelial carcinoma; Neuroendocrine differentiation
Prognostic Significance of Neuroendocrine Differentiation in Prostate Adenocarcinoma
Keywords: تمایز نوروندوکرین; Neuroendocrine differentiation; Prognosis; Prostate cancer
Prognostic significance of tumor grading and staging in mammary carcinomas with neuroendocrine differentiation
Keywords: تمایز نوروندوکرین; Neuroendocrine carcinoma; Invasive mammary carcinoma; Breast; Prognostic factors; Neuroendocrine differentiation; Ki-67
Roles of cAMP and cAMP-dependent protein kinase in the progression of prostate cancer: Cross-talk with the androgen receptor
Keywords: تمایز نوروندوکرین; Androgen receptor; PKA; cAMP; Prostate cancer; Androgen-dependence; Androgen-independence; Neuroendocrine differentiation; Phosphodiesterases; β-Adrenergic receptor; Adenylyl cyclase;
MnSOD drives neuroendocrine differentiation, androgen independence, and cell survival in prostate cancer cells
Keywords: تمایز نوروندوکرین; MnSOD; Prostate cancer; Neuroendocrine differentiation; Androgen independence; Redox modulation; Free radicals;
Androgen Depletion Induces Senescence in Prostate Cancer Cells through Down-regulation of Skp2
Keywords: تمایز نوروندوکرین; ADT; androgen deprivation therapy; AIPC; androgen-independent prostate cancer; AR; androgen receptor; CS; charcoal-stripped fetal bovine serum; EMT; epithelial-to-mesenchymal transition; HP1β; heterochromatin protein 1β; IL-8; interleukin-8; IGFBP3; ins
Granins and granin-related peptides in neuroendocrine tumours
Keywords: تمایز نوروندوکرین; Neuroendocrine tumours; Neuroendocrine differentiation; Granins; Granin-derived peptides; Chromogranins; Secretogranins; Prohormone convertases; Immunohistochemistry
Development of Carcinoid Tumour in Hormonally Treated Adenocarcinoma of the Prostate
Keywords: تمایز نوروندوکرین; Prostate; Adenocarcinoma; Hormone refractory; Carcinoid; Carcinoid syndrome; Neuroendocrine differentiation; Androgen deprivation therapy
Oncogenic activation of androgen receptor
Keywords: تمایز نوروندوکرین; Neuroendocrine differentiation; Neuropeptides; Src tyrosine kinase; Androgen receptor activation; Tyrosine kinase inhibitor; Hormone refractory prostate cancers
Neuroendocrine differentiation is involved in chemoresistance induced by EGF in prostate cancer cells
Keywords: تمایز نوروندوکرین; Prostate cancer; Neuroendocrine differentiation; Chemotherapy
Pathological Effects of Prostate Cancer Correlate With Neuroendocrine Differentiation and PTEN Expression After Bicalutamide Monotherapy
Keywords: تمایز نوروندوکرین; prostatic neoplasms; treatment failure; bicalutamide; PTEN phosphohydrolase; epidermal growth factor; ADT; androgen deprivation therapy; BCR; biochemical recurrence; CgA; chromogranin A; ECE; extracapsular extension; HER; human epidermal receptor; IHC; im
Neuroendocrine breast carcinoma metastatic to renal cell carcinoma and ipsilateral adrenal gland
Keywords: تمایز نوروندوکرین; Renal cell carcinoma; Breast cancer; Neuroendocrine differentiation; Cancer to cancer metastasis;
Comparison between two commercially available chromogranin A assays in detecting neuroendocrine differentiation in prostate cancer and benign prostate hyperplasia
Keywords: تمایز نوروندوکرین; Prostate cancer; Neuroendocrine differentiation; Chromogranin A
NeuroD1 Expression in Human Prostate Cancer: Can It Contribute to Neuroendocrine Differentiation Comprehension?
Keywords: تمایز نوروندوکرین; Prostate cancer; Neuroendocrine differentiation; Chromogranin A; Synaptophysin; CD56; NeuroD1
Androgen dependent regulation of protein kinase A subunits in prostate cancer cells
Keywords: تمایز نوروندوکرین; Prostate cancer; Protein kinase A (PKA); Catalytic subunit; Neuroendocrine differentiation; Androgen
Comprehensive expression analysis of l-dopa decarboxylase and established neuroendocrine markers in neoadjuvant hormone-treated versus varying Gleason grade prostate tumors
Keywords: تمایز نوروندوکرین; Neuroendocrine differentiation; Prostate cancer; Chromogranin A; l-Dopa decarboxylase; Androgen receptor